author-photo

Swaminathan Padmanabhan Iyer

University of Texas MD Anderson Cancer Center
Houston Methodist Hospital

111

Papers

1734

Citations

Citation Trend

Filter By

Papers (77) Sort By

Journal Conference Others

TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Emerging Therapeutic Landscape of Peripheral T-Cell Lymphomas Based on Advances in Biology: Current Status and Future Directions

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Imaging Surveillance of Limited-Stage Classic Hodgkin Lymphoma Patients after PET-CT Documented First Remission

2020 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
CD8 expression in anaplastic large cell lymphoma (ALCL) correlates with non-common morphologic variants and T-cell antigen expression suggesting biological differences with CD8-negative ALCL

2020 Human Pathology
Show All
- Source
- Cite
- Save
Citations (4)
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

2020 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (5)
SARS-CoV-2 in multiple myeloma: initial observation and management

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (2)
Haemophagocytic lymphohistiocytosis (HLH) in patients with large B-cell lymphoma treated with standard of care (SOC) axicabtagene ciloleucel (Axi-cel).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
T-cell lymphoma secondary to checkpoint inhibitor therapy

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (12)
Cord Blood Regulatory T Cells Do Not Impair Anti-Myeloma Effect of Conventional T Cells

2020 Biology of Blood and Marrow Transplantation
Show All
- Source
- Cite
- Save
Citations (0)
Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia.

2020 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (4)